Skip to content

BEKAR

Active
Private limited company·Activiteiten van huisartspraktijken· 5 yrs active
Woudlaan 78 ·1950 Kraainem, Belgium
KBO/BCE: BE 0770.898.590
Watch Print / PDF
Age5 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of BEKAR is 0.2% (very low). The 2024 annual accounts show equity of €157k and a net result of €35k. Equity is growing by ~77.2% per year across the filed fiscal years. Its solvency ranks better than 59% of 6584 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 4 annual accounts.

Signals

2 signals · with evidence
Consistently profitable
Positive net result in the two most recent financial years (2023 and 2024).
View the result trend
Growing equity
Equity grew over 2022-2024. Profits are largely retained rather than distributed.
View the equity trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Deadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 18 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 21-07-2025, 10 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
How we compute the deadline
The year end is derived from 4 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 nothing on record not filed -
31-12-2024 31-07-2025 21-07-2025 10 d early 2025-00310243
31-12-2023 31-07-2024 31-08-2024 31 d late 2024-00426375
31-12-2022 31-07-2023 01-09-2023 32 d late 2023-00408802
31-12-2021 31-07-2022 12-09-2022 43 d late 2022-20431356

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2021, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.2% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€35k-31.1%
Working capital€146k+78.4%

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 21-07-2025 with the NBB · fiscal year 2024 · micro
€0€20k€40k€60kOperating result 2021: €40k€40kNet result 2021: €31k€31kOperating result 2022: €40k€40kNet result 2022: €31k€31kOperating result 2023: €65k€65kNet result 2023: €51k€51kOperating result 2024: €41k€41kNet result 2024: €35k€35k2021202220232024
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~77.2%/year over 4 fiscal years, indicative, assuming unchanged policy.
€0€250k€500k€750k2025: €271k (€259k - €284k)2026: €481k (€466k - €496k)2027: €852k (€832k - €873k)2021: €33k2022: €33k2023: €84k2024: €157k2021202220232024202520262027
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 73.5% 66.7%
better than 59% of 6584 sector peers
Net result €35k €46k
better than 42% of 6578 sector peers
Equity €157k €79k
better than 72% of 6584 sector peers
Gross operating margin €88k €78k
better than 54% of 6586 sector peers
Staff costs €34k €21k
higher than 66% of 1212 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P59
2021: P80 · n=18482022: P77 · n=36852023: P60 · n=53472024: P59 · n=65842021 2024
Weakening position over 2021-2024 · n=1848-6584
Net result P42
2021: P41 · n=18482022: P43 · n=36832023: P59 · n=53462024: P42 · n=65782021 2024
Stable position over 2021-2024 · n=1848-6578
Equity P72
2021: P34 · n=18482022: P35 · n=36852023: P57 · n=53492024: P72 · n=65842021 2024
Improving position over 2021-2024 · n=1848-6584
Gross operating margin P54
2021: P31 · n=18492022: P34 · n=36812023: P65 · n=53432024: P54 · n=65862021 2024
Improving position over 2021-2024 · n=1849-6586
Describes the position versus peers, not a forecast.
EBITDA
€52k
-20.5% 21-24
Net profit
€35k
-31.1% 21-24
Cash flow
€46k
-9.6% 21-24
Total assets
€214k
+85.1% 21-24
Equity
€157k
+87.4% 21-24
Working capital
€146k
+78.4% 21-24
Employees (FTE)
1
+11.1% 21-24
Staff costs
€34k
+16.5% 21-24
Show 11 other metrics
Income taxes
€12k
-18.7% 21-24
Debt
€57k
+79.0% 21-24
Debt ≤ 1y
€26k
-19.0% 21-24
Debt > 1y
€31k
- 21-24
Current ratio
6.69
+86.7% 21-24
Quick ratio
6.69
+86.7% 21-24
Solvency
73.5%
+1.3% 21-24
Debt / equity
0.36
-4.5% 21-24
ROE
22.1%
-63.2% 21-24
ROA
16.2%
-62.8% 21-24
Interest coverage
28.17
-95.0% 21-24
Figures by fiscal year
Fiscal year2024
Depositmicro
Revenue-
EBITDA€52k
Net profit€35k
Cash flow€46k
Staff costs€34k
Income taxes€12k
Dividends-
Total assets€214k
Equity€157k
Debt€57k
of which ≤ 1y€26k
of which > 1y€31k
Working capital€146k
Employees (FTE)1.0
Ratios (computed)
2024
Current ratio6.69
Quick ratio6.69
Working capital ratio68.3%
Solvency73.5%
Debt / equity0.36
Long-term debt ratio0.20
Interest coverage28.17
Gross margin-
Net margin-
ROA16.2%
ROE22.1%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2024
Full annual accounts (22 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€214k
Fixed assets 21/28€42k
Tangible fixed assets 22/27€42k
Current assets 29/58€172k
Amounts receivable within one year 40/41€162k
Cash & bank 54/58€9k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€214k
Equity 10/15€157k
Contributions / capital 10/11€2k
Accumulated profits (losses) 14€155k
Amounts payable 17/49€57k
Amounts payable after one year 17€31k
Amounts payable within one year 42/48€26k
Trade debts payable within one year 44€2k
Income statement
Gross operating margin 9900€88k
Operating result 9901€41k
Financial income 75€8k
Financial charges 65€2k
Result before taxes 9903€47k
Income taxes 67/77€12k
Net result for the period 9904€35k
Result to be appropriated 9905€35k
This table shows the latest fiscal year. 3 prior years, with figures and ratios, belong to a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2024 · computed
93 / 100 Excellent
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

on the map · from the address register
exact location from the address register On OpenStreetMap

Establishment units

1 location
BEKAR
Charbolaan 57, 1030 SchaarbeekActiviteiten van huisartspraktijken
since 20212.319.510.223
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels2
Ground area506 m²
Buildings2
Building footprint245 m²
Volume (LiDAR)3,437 m³
Tallest building18.9 m · ±6 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (50%) Brussels 1 (50%)
Parcel (capakey) Region Area Buildings Height / fl.
21905C0060/00L003 Brussels 366 m² 1 · 187 m² 18.9 m · 6 fl.
22002B0155/00X004 Flanders 141 m² 1 · 58 m² 9.2 m · 2 fl.
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

1 acts
Address history · 1
10-05-2024
Registered-office move
All acts · 1 updated 2 years ago
2024
10-05-2024 Registered office moved from Schaarbeek to Kraainem Registered-office change
  • Charbolaan 57, 1030 Schaarbeek → Woudlaan 78, 1950 Kraainem

Analysis

Financial profile

5 of 5 axes measured
Health93Profitability100Solvency100Growth78Stability94
93 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 93
Profitability 100
Solvency 100
Growth 78
Stability 94

Credit advice

verdict per customer and amount

May this customer buy amount X on invoice? Enter the amount and the payment term. This page computes a GREEN, AMBER or RED verdict from them, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Comparable size, same sector

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Huisartspraktijken86210Activiteiten van huisartspraktijken86210Praktijken van specialisten86220Activiteiten van medisch specialisten86220
Primary activity highlighted.
Names & trade names
Legal nameNL BEKAR
Registered office
Woudlaan 78
1950 Kraainem, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.